Steward Partners Investment Advisory’s Regeneron Pharmaceuticals REGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$2.25M Sell
4,286
-1,082
-20% -$568K 0.02% 681
2025
Q1
$3.4M Buy
5,368
+741
+16% +$470K 0.03% 501
2024
Q4
$3.3M Buy
4,627
+981
+27% +$699K 0.03% 484
2024
Q3
$3.83M Buy
3,646
+159
+5% +$167K 0.04% 439
2024
Q2
$3.66M Buy
3,487
+600
+21% +$631K 0.04% 410
2024
Q1
$2.78M Buy
2,887
+74
+3% +$71.2K 0.03% 477
2023
Q4
$2.47M Sell
2,813
-79
-3% -$69.4K 0.03% 450
2023
Q3
$2.38M Buy
2,892
+465
+19% +$383K 0.04% 426
2023
Q2
$1.74M Sell
2,427
-285
-11% -$205K 0.03% 521
2023
Q1
$2.23M Buy
2,712
+503
+23% +$413K 0.04% 444
2022
Q4
$1.59M Sell
2,209
-504
-19% -$364K 0.03% 519
2022
Q3
$1.87M Sell
2,713
-132
-5% -$90.9K 0.03% 451
2022
Q2
$1.68M Sell
2,845
-911
-24% -$539K 0.03% 481
2022
Q1
$2.62M Buy
3,756
+53
+1% +$37K 0.04% 398
2021
Q4
$2.34M Buy
3,703
+475
+15% +$300K 0.04% 449
2021
Q3
$1.95M Buy
3,228
+60
+2% +$36.3K 0.03% 464
2021
Q2
$1.77M Sell
3,168
-1,726
-35% -$964K 0.03% 481
2021
Q1
$2.32M Buy
4,894
+1,339
+38% +$634K 0.04% 397
2020
Q4
$1.72M Buy
3,555
+678
+24% +$327K 0.04% 398
2020
Q3
$1.61M Buy
2,877
+1,717
+148% +$961K 0.04% 362
2020
Q2
$723K Buy
1,160
+162
+16% +$101K 0.02% 536
2020
Q1
$487K Buy
998
+216
+28% +$105K 0.02% 563
2019
Q4
$293K Sell
782
-2
-0.3% -$749 0.01% 770
2019
Q3
$217K Buy
784
+203
+35% +$56.2K 0.01% 820
2019
Q2
$181K Sell
581
-244
-30% -$76K 0.01% 851
2019
Q1
$338K Buy
+825
New +$338K 0.01% 610
2018
Q4
Sell
-336
Closed -$136K 1836
2018
Q3
$136K Buy
336
+37
+12% +$15K 0.01% 826
2018
Q2
$103K Sell
299
-11
-4% -$3.79K 0.01% 837
2018
Q1
$106K Sell
310
-59
-16% -$20.2K 0.01% 759
2017
Q4
$138K Buy
369
+307
+495% +$115K 0.01% 586
2017
Q3
$27K Buy
62
+9
+17% +$3.92K ﹤0.01% 860
2017
Q2
$26K Hold
53
﹤0.01% 793
2017
Q1
$20K Buy
53
+32
+152% +$12.1K ﹤0.01% 761
2016
Q4
$7K Buy
+21
New +$7K ﹤0.01% 619